Early real-world data suggest that weekly at-home subcutaneous lecanemab may offer a feasible alternative to ongoing IV maintenance treatment for early Alzheimer’s disease.

Drs Anne Lenore Ackerman and Barbara W. Trautner discuss recent changes to the guidelines for the diagnosis and management of complicated UTIs.

In two studies in retinal disease, faricimab shows improved vision and a reduced injection burden in people who switched from ...

A Medscape commentary asks whether older physicians should be tested for competence. Readers answer with a question of their own: Why single out age?

Infants who do not receive intramuscular vitamin K prophylaxis at birth have higher odds of bleeding episodes and intracranial hemorrhage during the first 6 months of life.

Gradually spacing belimumab doses appears feasible in patients with prolonged remission from systemic lupus erythematosus, ...

Rapid weight loss with GLP-1 drugs is changing aesthetic practice, as surgeons address facial volume loss, excess skin, and ...

A multidisciplinary group of experts has issued recommendations for managing systemic cancer therapies in patients undergoing ...

Breast, colon, and cervical cancer incidence and mortality have improved for First Nations patients, but survival is ...

Among Black children, percent African ancestry is associated with an increased risk for asthma and allergen-specific sensitization.

As patents expire, generic injectable semaglutide could become available at a fraction of current branded prices — around $28-$140 per person-year — in about 162 countries by the end of 2026.

Following bariatric surgery, women with food addiction report a higher intake of ultraprocessed foods, greater anxiety, lower ...